SCHEMBL4403535

SCHEMBL4403535

Cc1ccc(N2CCC(Oc3ccc(S(=O)(=O)NC4CCCCC4)cn3)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
CYP3A4 P08684 2/20 0.53
TSHR P16473 1/20 0.53
GAA P10253 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
TP53 P04637 1/20 0.44
KIT P10721 2/20 0.43
RECQL P46063 2/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 1/20 0.42
KDM4E B2RXH2 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
ACACB O00763 1/20 0.40
UCHL1 P09936 1/20 0.40
USP30 Q70CQ3 1/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4401665 0.90 KIT (0.43) ALDH1A1CYP3A4TSHRKITRECQL
SCHEMBL10113339 0.87 ALDH1A1 (0.46) ALDH1A1GAASMN1; SMN2TP53RECQL
SCHEMBL15480694 0.85 HTT (0.52) ALDH1A1CYP3A4SMN1; SMN2TP53RECQL
SCHEMBL4405695 0.84 GPR119 (0.60) GPR119MEN1KMT2A
SCHEMBL4405690 0.84 SCN8A (0.43) ALDH1A1CYP3A4SMN1; SMN2TP53KIT
SCHEMBL12199349 0.83 HTR1A (0.46) GAASMN1; SMN2TP53HTT
SCHEMBL4408231 0.83 PRKAA2 (0.56) ALDH1A1GAASMN1; SMN2TP53HTT
SCHEMBL4401672 0.81 LIPE (0.44) CYP3A4HTTGPR119UCHL1USP30
SCHEMBL4401696 0.81 THRB (0.54) CYP3A4GPR119
SCHEMBL4454172 0.80 USP30 (0.45) GPR119UCHL1USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115838-A1 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same RIGEL PHARMACEUTICALS, INC. (US) 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115838-A1 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same PRKAA1, PRKAA2, PRKAG1 ALDH1A1 1121/4885CYP3A4 2484/4885TSHR 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.